A detailed history of Manchester Capital Management LLC transactions in Viatris Inc stock. As of the latest transaction made, Manchester Capital Management LLC holds 4,841 shares of VTRS stock, worth $55,913. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,841
Previous 4,875 0.7%
Holding current value
$55,913
Previous $58,000 12.07%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$10.05 - $12.02 $341 - $408
-34 Reduced 0.7%
4,841 $51,000
Q1 2024

May 06, 2024

BUY
$11.27 - $13.53 $462 - $554
41 Added 0.85%
4,875 $58,000
Q4 2023

Feb 08, 2024

BUY
$8.77 - $10.85 $3,271 - $4,047
373 Added 8.36%
4,834 $52,000
Q3 2023

Nov 09, 2023

BUY
$9.59 - $11.35 $95 - $113
10 Added 0.22%
4,461 $43,000
Q2 2023

Aug 14, 2023

BUY
$9.02 - $10.29 $7,342 - $8,376
814 Added 22.38%
4,451 $44,000
Q1 2023

May 09, 2023

SELL
$9.2 - $12.26 $5,823 - $7,760
-633 Reduced 14.82%
3,637 $34,000
Q4 2022

Feb 09, 2023

SELL
$8.72 - $11.56 $3,174 - $4,207
-364 Reduced 7.85%
4,270 $47,000
Q3 2022

Nov 08, 2022

SELL
$8.48 - $11.13 $1,238 - $1,624
-146 Reduced 3.05%
4,634 $39,000
Q2 2022

Aug 10, 2022

BUY
$9.95 - $12.27 $2,587 - $3,190
260 Added 5.75%
4,780 $50,000
Q1 2022

May 09, 2022

SELL
$9.81 - $15.4 $3,394 - $5,328
-346 Reduced 7.11%
4,520 $49,000
Q4 2021

Feb 10, 2022

SELL
$12.09 - $14.68 $2,792 - $3,391
-231 Reduced 4.53%
4,866 $66,000
Q3 2021

Nov 12, 2021

BUY
$13.25 - $15.13 $3,286 - $3,752
248 Added 5.11%
5,097 $69,000
Q2 2021

Aug 16, 2021

BUY
$12.97 - $16.15 $3,125 - $3,892
241 Added 5.23%
4,849 $69,000
Q1 2021

May 13, 2021

SELL
$13.59 - $18.54 $3,710 - $5,061
-273 Reduced 5.59%
4,608 $64,000
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $69,798 - $91,469
4,881 New
4,881 $91,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Manchester Capital Management LLC Portfolio

Follow Manchester Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Capital Management LLC with notifications on news.